NCT05589883 is a NA clinical trial of EMPOWER-Latinx in Informal Caregiver, sponsored by Memorial Sloan Kettering Cancer Center.

Who is sponsoring NCT05589883?

NCT05589883 is sponsored by Memorial Sloan Kettering Cancer Center.

What drugs are being tested in NCT05589883?

Interventions in NCT05589883: EMPOWER-Latinx.

What condition does NCT05589883 study?

NCT05589883 studies Informal Caregiver.

Is NCT05589883 still recruiting?

NCT05589883 is currently withdrawn. Last updated 9 November 2023.

Last reviewed 2023-11-09 · How we verify

NCT05589883

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study of the EMPOWER Program for Latinx Caregivers of ICU Patients

Withdrawn NA Last updated 9 November 2023

What this trial tests

NA trial testing EMPOWER-Latinx in Informal Caregiver. Withdrawn.

Timeline

18 October 2022

Primary endpoint
7 November 2023

7 November 2023

Quick facts

Lead sponsor	Memorial Sloan Kettering Cancer Center
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Start date	18 October 2022
Primary completion	7 November 2023
Estimated completion	7 November 2023

Drugs / interventions tested

EMPOWER-Latinx

Conditions studied

Informal Caregiver — all drugs for Informal Caregiver →

Sponsor

Memorial Sloan Kettering Cancer Center — full company profile →

Who can join

18 and older, any sex, with Informal Caregiver. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The researchers are doing this study to find out whether EMPOWER (Enhancing \& Mobilizing the Potential for Wellness \& Emotional Resilience) may reduce emotional distress in Latinx caregivers of patients in the ICU.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Informal Caregiver

Currently open trials in the same condition.

NCT05571488 — Swiss Cohort of Health Professionals and Informal Caregivers · recruiting

Other Memorial Sloan Kettering Cancer Center trials

Trials by the same sponsor.

NCT07566377 — Cord Blood Transplantation in Children and Young Adults With Blood Cancer · Phase 2 · recruiting
NCT07507643 — A Study of Methylprednisolone in People Having Liver Surgery · Phase 3 · recruiting
NCT07483307 — A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer · Phase 2 · recruiting
NCT07459673 — HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term · Phase 2 · recruiting
NCT07449195 — A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05589883 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center
Last refreshed: 9 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05589883.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing